ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leroy, O.
Right arrow Articles by Beaucaire, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leroy, O.
Right arrow Articles by Beaucaire, G.
Eur Respir J 2002; 20:432-439
Copyright ©ERS Journals Ltd 2002


Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens

O. Leroy1, P. Giradie1, Y. Yazdanpanah1, H. Georges1, S. Alfandari1, V. Sanders1, P. Devos2 and G. Beaucaire1

1 Intensive Care Unit and Infectious Diseases Dept, Lille University Medical School, Chatiliez Hospital, Tourcoing and 2 Dept of Biostatistics, Lille University Medical School, Lille, France

CORRESPONDENCE: O. Leroy, Service de Réanimation Médicale et Maladies Infectieuses, Centre Hospitalier, Rue du President Coty, 59208, Tourcoing, France. Fax: 33 320694439. E-mail: oyleroy@ch-tourcoing.fr

Keywords: antibiotics, intensive care, nosocomial pneumonia, pneumonia, resistance

Received: August 23, 2001
Accepted April 11, 2002

Adequate antimicrobial therapy is a main approach employed to decrease the mortality associated with hospital-acquired pneumonia (HAP). All methods that optimise empirical treatment without increasing antibiotic selective pressure are relevant. Categorisation of patients according to HAP time of onset, severity and risk factors (American Thoracic Society (ATS) classification) or duration of mechanical ventilation and prior antibiotics (Trouillet's classification) are two such methods. The aim of this study was to catagorise patients with HAP according to these classifications and to determine the frequency of resistant pathogens and the most adequate antimicrobial regimens in each group.

A total 124 patients with bacteriologically proven HAP were studied. The ATS classification categorised patients by increasing frequency of resistant pathogens from 0–30.3%. The ATS empirical antibiotic recommendations appeared valid but proposed combinations including vancomycin for 72.5% of patients. Trouillet's classification categorised patients into four groups with a frequency of resistant pathogens from 4.9–35.6%. Vanomycin was proposed for 48.5% of patients.

The American Thoracic Society classification appears to be more specific than Trouillet's for predicting the absence of resistant causative pathogens in hospital-acquired pneumonia but could lead to a greater use of vanomycin. Stratification combining the two classifications is an interesting alternative.




This article has been cited by other articles:


Home page
ChestHome page
A. Torres
Implementation of Guidelines on Hospital-Acquired Pneumonia
Chest, October 1, 2005; 128(4): 1900 - 1802.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. Ioanas, M. Cavalcanti, M. Ferrer, M. Valencia, C. Agusti, J. Puig de la Bellacasa, and A. Torres
Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Eur. Respir. J., December 1, 2003; 22(6): 876 - 882.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.